Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,151
Recruiting: 2,258
Ph III recruiting: 267
Growth YoY: +13.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 601–612 of 612 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01510002	Prophylactic Central Neck Dissection for Papillary Thyroid Cancer	completed	N/A	640	Jagiellonian UniversityOTHER	1	Jan 13, 2012	clinicaltrials
NCT01387061	Resection for Multiple Hepatocellular Carcinomas (HCC)	completed	N/A	87	University of MilanOTHER	1	Sep 20, 2011	clinicaltrials
NCT00225927